RxDoctor Payments Data

Eric Emanski, MD

Orthopaedic Surgery of the Spine · State College, PANPI 1518233501

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $75,928 of the $87,893 with a category attached, or 86.4%. The Institute Of Musculoskeletal Science And Education accounts for 87.0% of it on its own, with 14 other manufacturers making up the rest.

$87,893in general payments, 2019–2025

Across 58 payments — averaging $1515.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • The Institute Of Musculoskeletal Science And Education$76K
  • Mirus, LLC$4K
  • Camber Spine Technologies LLC$2K
  • Globus Medical$2K
  • Stryker$1K
  • 4web, Inc.$1K
  • plus $2K from 9 others

What the payments were for

  • Royalty or licence$75,92886%
  • Consulting fees$6,4827%
  • Travel & lodging$2,9383%
  • Food & beverage$2,5453%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$87,893 in reported general payments places this provider in the 75th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$73,377
Medicare patients
92
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tizanidine Hcl33$612
Methocarbamol15$206
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$167
Gabapentin16$115

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in State College

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →